FTC Targets Pharmacy Middlemen for Alleged Inflated Insulin Prices
Friday, 20 September 2024, 09:54
FTC Takes Action Against Pharmacy Middlemen
The Federal Trade Commission (FTC) has filed a lawsuit against several pharmacy benefit managers, including CVS, Cigna, and UnitedHealth, claiming they have inflated the prices of insulin and other medications. This legal action follows a previous report stating that these companies played a role in driving up drug costs.
Allegations of Price Inflation
- CVS
- Cigna
- UnitedHealth
- Optum
- Caremark
- Express Scripts
This lawsuit aims to bring transparency and fairness back to medication pricing.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.